DettelbachHRAviadoDM.Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.J Clin Pharmacol1985; 25: 8–26.
2.
ChoYWAviadoDM.Clinical pharmacology for pediatricians II—Antisickling agents with special reference to new vasoery-thro-active drugs.J Clin Pharmacol1982; 22: 1–13.
3.
AmbrusJLAmbrusCMGastparHBannermanRBettigoleRFriedmanS.Studies on vaso-occlusive crisis of sickle cell disease. I. Effect of pentoxifylline.J Med1979; 10: 445–56.
4.
KellerFLeonhardtH.Amelioration of blood viscosity in sickle cell anemia by pentoxifylline.J Med1979; 10: 429–33.
5.
SeiffgeDBertholdRBertholdF.Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results.Klin Wochenschr1983; 61: 1159–60.
6.
KhoslaAAChintuC.A pilot study: an open clinical trial of pentoxifylline in patients with painful sickle cell crises.E Afr Med J1984; 11: 829–36.
